Ultrafiltration is Associated With Fewer Rehospitalizations than Continuous Diuretic Infusion in Patients With Decompensated Heart Failure: Results From UNLOAD

被引:104
|
作者
Costanzo, Maria Rosa [1 ]
Saltzberg, Mitchell T. [2 ]
Jessup, Mariell
Teerlink, John R. [3 ]
Sobotka, Paul A. [4 ]
机构
[1] Midwest Heart Fdn, Lombard, IL USA
[2] Univ Penn, Dept Med, Div Cardiol, Christiana Hosp, Philadelphia, PA 19104 USA
[3] Univ Calif San Francisco, Cardiol Sect, San Francisco Vet Affairs Med Ctr, Sch Med, San Francisco, CA 94143 USA
[4] Ohio State Univ, Affiliate Fac, Columbus, OH 43210 USA
关键词
Ultrafiltration; diuretics; heart failure; BODY-FLUID; FUROSEMIDE; RESISTANCE; OUTCOMES; REGISTRY; TRIAL; DEATH;
D O I
10.1016/j.cardfail.2009.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Compare outcomes of ultrafiltration (UF) versus standard intravenous (IV) diuretics by continuous infusion or bolus injection in volume overloaded heart failure (HF) patients. In the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated heart Failure (UNLOAD) study, UF produced greater fluid reduction and fewer HF rehospitalizations than IV diuretics in 200 hospitalized HF patients. Outcomes may be due to greater fluid removal, but UF removes more sodium/unit volume than diuretics. Methods and Results: Outcomes of 100 patients randomized to UF were compared with those of patients randomized to standard IV diuretic therapy with continuous infusion (32) or bolus injections (68). Choice of diuretic therapy was by the treating physician. Forty-eight hour weight loss (kg): 5.0 +/- 3.1 UF, 3.6 +/- 3.5 continuous infusion, and 2.9 +/- 3.5 bolus diuretics (P = .001 UF versus bolus diuretic; P > .05 for the other comparisons). Net fluid loss (L): 4.6 +/- 2.6 UF, 3.9 +/- 2.7 continuous infusion, and 3.1 +/- 2.6 bolus diuretics (P < .001 UF versus bolus diuretic; P > .05 for the other comparisons). At 90 days, rehospitalizations plus unscheduled visits for HF/patient (rehospitalization equivalents) were fewer in UF group (0.65 +/- 1.36) than in continuous infusion (2.29 +/- 3.23; P = .016 versus UF) and bolus diuretics (1.31 +/- 1.87; P = .050 versus UF) groups. No serum creatinine differences occurred between groups up to 90 days. Conclusions: Despite similar fluid loss with UF and continuous diuretic infusion, fewer HF rehospitalizations equivalents occurred only with UF. Removal of isotonic fluid by UF compared with hypotonic urine by diuretics more effectively reduces total body sodium in congested HE patients. (J Cardiac Fail 2010;16:277-284)
引用
收藏
页码:277 / 284
页数:8
相关论文
共 50 条
  • [31] Increase of coronary flow after levosimendan infusion is associated with improvement in cardiac performance in patients with decompensated heart failure
    Ikonomidis, Ignatios
    Parissis, John
    Paraskevaidis, Ioannis
    Kourea, Kaliroi
    Panou, Fotios
    Bistola, Vasiliki
    Filipatos, Gerasimos
    Kremastinos, Dimitrios T.
    CIRCULATION, 2006, 114 (18) : 619 - 619
  • [32] EVALUATION OF RISK FACTORS ASSOCIATED WITH THIOCYANATE TOXICITY IN PATIENTS WITH DECOMPENSATED HEART FAILURE RECEIVING SODIUM NITROPRUSSIDE INFUSION
    Jones, Mathew
    Crow, Jessica
    Goodwin, Haley
    Lewin, John
    Lindsley, John
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U266 - U266
  • [33] Increase of coronary flow after levosimendan infusion is associated with improvement in cardiac performance in patients with decompensated heart failure
    Ikonomidis, I.
    Parissis, I.
    Paraskevaidis, I.
    Kourea, K.
    Filippatos, G.
    Kremastinos, D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 43 - 43
  • [34] Impact of Dopamine Infusion on Renal Function in Hospitalized Heart Failure Patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
    Giamouzis, Gregory
    Butler, Javed
    Starling, Randall C.
    Karayannis, George
    Nastas, John
    Parisis, Charalambos
    Rovithis, Dimitrios
    Economou, Dimitrios
    Savvatis, Konstantinos
    Kirlidis, Themistoklis
    Tsaknakis, Themistoklis
    Skoularigis, John
    Westermann, Dirk
    Tschope, Carsten
    Triposkiadis, Filippos
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (12) : 922 - 930
  • [35] Baseline albumin predicts worsening renal function in acute decompensated heart failure patients receiving continuous infusion loop diuretics
    Barnes, Megan M.
    Dorsch, Michael P.
    Kim, Susie
    Aaronson, Keith
    Koelling, Todd
    Bleske, Barry E.
    PHARMACOTHERAPY, 2012, 32 (10): : E187 - E187
  • [36] Do Any Patients with Acute Decompensated Heart Failure and Acute Cardio-Renal Syndrome Benefit from Ultrafiltration?
    Turner, Jeffrey M.
    Testani, Jeffrey M.
    SEMINARS IN DIALYSIS, 2014, 27 (03) : 231 - 233
  • [37] Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF
    Voors, Adriaan A.
    Davison, Beth A.
    Teerlink, John R.
    Felker, G. Michael
    Cotter, Gad
    Filippatos, Gerasimos
    Greenberg, Barry H.
    Pang, Peter S.
    Levin, Bruce
    Hua, Tsushung A.
    Severin, Thomas
    Ponikowski, Piotr
    Metra, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (11) : 1230 - 1240
  • [38] EXTRACORPOREAL CONTINUOUS VENO-VENOUS ULTRAFILTRATION IN PATIENTS WITH ACUTE HEART FAILURE REFRACTORY TO DIURETIC THERAPY: A SINGLE-CENTER PILOT EXPERIENCE
    Somaschini, A.
    Buscemi, M.
    Cornara, S.
    Astuti, M.
    Cordone, S.
    Botta, M.
    Pentimalli, F.
    Bellone, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [39] Hypotension associated with nesiritide infusion in patients with decompensated heart failure is related to large volume diuresis: Implications for monitoring and dose adjustments
    Tang, WHW
    Militello, M
    Barcelona, R
    Young, JB
    Francis, GS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 192A - 192A
  • [40] Decreased beneficial effects of oral heart failure medications in patients with acute decompensated heart failure and hyperglycemia: results from an international observational cohort
    Akiyama, E.
    Cinotti, R.
    Arrigo, M.
    Lassus, J.
    Miro, O.
    Celutkiene, J.
    Cohen-Solal, A.
    Maggioni, A. P.
    Mueller, C.
    Parenica, J.
    Spinar, J.
    Sato, N.
    Tamura, K.
    Kimura, K.
    Mebazaa, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3956 - 3956